Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00051298
Recruitment Status : Completed
First Posted : January 9, 2003
Last Update Posted : June 12, 2007
Sponsor:
Information provided by:
Eli Lilly and Company